Susquehanna International Group
MBOT icon

Susquehanna International Group’s Microbot Medical MBOT Stock Holding History

Susquehanna International Group’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$492K Sell
204,100
-14,600
-7% -$32.6K ﹤0.01% 9707
2025
Q4 		$437K Sell
218,700
-74,600
-25% -$177K ﹤0.01% 9120
2025
Q3 		$895K Buy
293,300
+263,300
+878% +$821K ﹤0.01% 7605
2025
Q2 		$75.6K Buy
30,000
+2,800
+10% +$6.7K ﹤0.01% 11942
2025
Q1 		$41.1K Buy
+27,200
New +$48.1K ﹤0.01% 11922

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group's MBOT Position: Q1 2026 in Review

Susquehanna International Group reduced its Microbot Medical (MBOT) stake by 26% in Q1 2026, selling an estimated $717K and leaving 924,307 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #5926.

Susquehanna International Group first reported a position in MBOT in Q3 2014 and has held it in 10 quarters since. The position peaked at $3.81M in Q3 2025. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Susquehanna International Group held 924,307 shares of Microbot Medical worth $2.23M as of Q1 2026.
  • Susquehanna International Group sold 320,816 Microbot Medical shares in Q1 2026, an estimated $717K.
  • Microbot Medical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5926 holding.
  • Susquehanna International Group first reported a position in Microbot Medical in Q3 2014 and has held it in 10 quarters since.
  • Susquehanna International Group's Microbot Medical position peaked at $3.81M in Q3 2025.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.